{"transactions":[{"id":352020,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:22:08.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":2827,"price":99.77,"value":282049.79,"ownership":{"direct":true},"balance_after":32822,"source":{"system":"sec-edgar","filing":"0001415889-23-003896","document":"form4-03032023_120343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003896/form4-03032023_120343.xml","form_type":"4"}},{"id":352766,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-22T23:40:17.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":41648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,882 on February 17, 2024, 13,883 on February 17, 2025 and 13,883 on February 17, 2026."}],"balance_after":41648,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":41648},"source":{"system":"sec-edgar","filing":"0001415889-23-003047","document":"form4-02222023_110207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003047/form4-02222023_110207.xml","form_type":"4"}},{"id":352765,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-22T23:40:17.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":10560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":35649,"source":{"system":"sec-edgar","filing":"0001415889-23-003047","document":"form4-02222023_110207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003047/form4-02222023_110207.xml","form_type":"4"}},{"id":359984,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-07-01T20:32:56.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":569,"price":108.65,"value":61821.85,"ownership":{"direct":true},"balance_after":25089,"source":{"system":"sec-edgar","filing":"0001415889-22-007180","document":"form4-07012022_010747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922007180/form4-07012022_010747.xml","form_type":"4"}},{"id":364713,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:33:00.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":706,"price":118.1503,"value":83414.1118,"ownership":{"direct":true},"balance_after":25658,"source":{"system":"sec-edgar","filing":"0001415889-22-002187","document":"form4-03022022_040347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002187/form4-03022022_040347.xml","form_type":"4"}},{"id":364712,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:33:00.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":2368,"price":122.41,"value":289866.88,"ownership":{"direct":true},"balance_after":26364,"source":{"system":"sec-edgar","filing":"0001415889-22-002187","document":"form4-03022022_040347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002187/form4-03022022_040347.xml","form_type":"4"}},{"id":365297,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:02:22.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":59708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,902 on February 18, 2023, 19,903 on February 18, 2024 and 19,903 on February 18, 2025."}],"balance_after":59708,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":59708},"source":{"system":"sec-edgar","filing":"0001415889-22-001731","document":"form4-02232022_050208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001731/form4-02232022_050208.xml","form_type":"4"}},{"id":365296,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:02:22.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":12812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":28732,"source":{"system":"sec-edgar","filing":"0001415889-22-001731","document":"form4-02232022_050208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001731/form4-02232022_050208.xml","form_type":"4"}},{"id":373728,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-07-06T21:09:11.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":19291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,430 on July 1, 2022, 6,430 on July 1, 2023 and 6,431 on July 1, 2024."}],"balance_after":19291,"derivative":{"exercise_price":116.4,"exercise_date":"2022-07-01","expiration_date":"2031-06-30","underlying":"Common Shares","underlying_shares":19291},"source":{"system":"sec-edgar","filing":"0001415889-21-003509","document":"form4-07062021_020756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003509/form4-07062021_020756.xml","form_type":"4"}},{"id":373727,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15394,"kind":"person","name":"Calamari Christopher J.","position":1,"cik":"0001868518","reported_name":"Calamari Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-07-06T21:09:11.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":3764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":15920,"source":{"system":"sec-edgar","filing":"0001415889-21-003509","document":"form4-07062021_020756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003509/form4-07062021_020756.xml","form_type":"4"}}]}